Literature DB >> 28637624

ETV6 in hematopoiesis and leukemia predisposition.

Hanno Hock1, Akiko Shimamura2.   

Abstract

The ETV6 (also known as TEL) gene encodes a transcriptional repressor that plays a critical role in hematopoiesis and in embryonic development. While somatic ETV6 translocations and missense mutations are frequently observed in human cancers, the role of ETV6 in malignant transformation was unclear. Recently, autosomal dominant germline ETV6 mutations were discovered in families with inherited thrombocytopenia and a propensity to develop hematological malignancy, unequivocally demonstrating a role for ETV6 in leukemogenesis. Studies of germline ETV6 mutations also uncovered an important function of ETV6 in megakaryocyte development. Here we discuss our current understanding of the role of ETV6 in malignancy and in hematopoiesis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALL; ETV6; MDS; Platelets; TEL; Thrombocytopenia

Mesh:

Substances:

Year:  2017        PMID: 28637624      PMCID: PMC5584538          DOI: 10.1053/j.seminhematol.2017.04.005

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  58 in total

1.  The ETS family member Tel antagonizes the Fli-1 phenotype in hematopoietic cells.

Authors:  B A Kwiatkowski; A G Zielinska-Kwiatkowska; T R Bauer; D D Hickstein
Journal:  Blood Cells Mol Dis       Date:  2000-02       Impact factor: 3.039

2.  Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation.

Authors:  Kazuhiro Maki; Honoka Arai; Kazuo Waga; Ko Sasaki; Fumihiko Nakamura; Yoichi Imai; Mineo Kurokawa; Hisamaru Hirai; Kinuko Mitani
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.

Authors:  Grazia Fazio; Chiara Palmi; Antonius Rolink; Andrea Biondi; Giovanni Cazzaniga
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

4.  Control of endothelial sprouting by a Tel-CtBP complex.

Authors:  M Guy Roukens; Mariam Alloul-Ramdhani; Bart Baan; Kazuki Kobayashi; Josi Peterson-Maduro; Hans van Dam; Stefan Schulte-Merker; David A Baker
Journal:  Nat Cell Biol       Date:  2010-09-12       Impact factor: 28.824

5.  Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function.

Authors:  M Guy Roukens; Mariam Alloul-Ramdhani; Alfred C O Vertegaal; Zeinab Anvarian; Crina I A Balog; André M Deelder; Paul J Hensbergen; David A Baker
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

6.  Downregulation of vertebrate Tel (ETV6) and Drosophila Yan is facilitated by an evolutionarily conserved mechanism of F-box-mediated ubiquitination.

Authors:  M Guy Roukens; Mariam Alloul-Ramdhani; Setareh Moghadasi; Marjolein Op den Brouw; David A Baker
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

7.  Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival.

Authors:  Hanno Hock; Eliza Meade; Sarah Medeiros; Jeffrey W Schindler; Peter J M Valk; Yuko Fujiwara; Stuart H Orkin
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

8.  The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription.

Authors:  K H M van Wely; M A Meester-Smoor; M J F W Janssen; A-J Aarnoudse; G C Grosveld; E C Zwarthoff
Journal:  Oncogene       Date:  2007-03-19       Impact factor: 9.867

9.  Analysis of TEL proteins in human leukemias.

Authors:  H Poirel; V Lacronique; M Mauchauffé; M Le Coniat; E Raffoux; M T Daniel; P Erickson; H Drabkin; R A MacLeod; H G Drexler; J Ghysdael; R Berger; O A Bernard
Journal:  Oncogene       Date:  1998-06-04       Impact factor: 9.867

10.  Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia.

Authors:  Federica Melazzini; Flavia Palombo; Alessandra Balduini; Daniela De Rocco; Caterina Marconi; Patrizia Noris; Chiara Gnan; Tommaso Pippucci; Valeria Bozzi; Michela Faleschini; Serena Barozzi; Michael Doubek; Christian A Di Buduo; Katerina Stano Kozubik; Lenka Radova; Giuseppe Loffredo; Sarka Pospisilova; Caterina Alfano; Marco Seri; Carlo L Balduini; Alessandro Pecci; Anna Savoia
Journal:  Haematologica       Date:  2016-06-30       Impact factor: 9.941

View more
  33 in total

Review 1.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

Review 2.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

Review 3.  The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Authors:  Ulrich H Weidle; Alexandra Epp; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2019 Jan-Feb       Impact factor: 4.069

4.  Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement.

Authors:  Timothy Carll; Anand Patel; Benjamin Derman; Elizabeth Hyjek; Angela Lager; Pankhuri Wanjari; Jeremy Segal; Olatoyosi Odenike; Shiraz Fidai; Daniel Arber
Journal:  Blood Adv       Date:  2020-10-13

5.  The correction of ETV6/RUNX1 translocation in acute lymphocytic leukemia cells: a new gene targeting system by homologous recombination mechanism.

Authors:  Mona Akbari; Sima Ebrahimabadi; Masoud Golalipour; Majid Shahbazi; Touraj Farazmandfar
Journal:  J Appl Genet       Date:  2019-10-10       Impact factor: 3.240

6.  Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6.

Authors:  Tekla Järviaho; Benedicte Bang; Vasilios Zachariadis; Fulya Taylan; Jukka Moilanen; Merja Möttönen; C I Edvard Smith; Arja Harila-Saari; Riitta Niinimäki; Ann Nordgren
Journal:  Blood Adv       Date:  2019-09-24

7.  The genetic risk of second cancers: should the therapy for acute lymphoblastic leukemia be individualized according to germline genetic makeup?

Authors:  Kathleen E A Felton; Christopher C Porter; Jun J Yang
Journal:  Expert Rev Precis Med Drug Dev       Date:  2018-09-03

8.  ETV6-related thrombocytopenia and leukemia predisposition.

Authors:  Jorge Di Paola; Christopher C Porter
Journal:  Blood       Date:  2019-06-27       Impact factor: 22.113

9.  Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.

Authors:  Valentina Nardi; Nora Ku; Matthew J Frigault; Adrian M Dubuc; Harrison Kwei Tsai; Philip C Amrein; Gabriela S Hobbs; Andrew M Brunner; Rupa Narayan; Meghan E Burke; Julia Foster; Paola Dal Cin; Marcela V Maus; Amir T Fathi; Hanno Hock
Journal:  Blood Adv       Date:  2020-01-14

Review 10.  Cell Fate Decisions: The Role of Transcription Factors in Early B-cell Development and Leukemia.

Authors:  Ute Fischer; Jun J Yang; Tomokatsu Ikawa; Daniel Hein; Carolina Vicente-Dueñas; Arndt Borkhardt; Isidro Sánchez-García
Journal:  Blood Cancer Discov       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.